InventHelp Inventor Develops Transport Device for a Portable Oxygen Concentrator (LGT-341)

“My wife uses an oxygen concentrator. She found carrying the machine by a strap over her shoulder to be painful,” said an inventor, fromHenderson, Nev., “so I invented the CART ASSIST. My design enables you to easily and effortlessly transport a standard oxygen concentrator.” https://mma.prnewswire.com/media/2099578/InventHelp_Logo_jpg_Logo.jpg The invention provides an effective way to transport an oxygen […]

AI Reshaping Global Labor Markets: US, Singapore Leading the Way, But Many Risk Falling Behind, Finds New Report Launched at Davos

Whiteshield released the 9th edition of the Global Labour Resilience Index (GLRI) in collaboration with Google Cloud, in an exclusive event held on the sidelines of the World Economic Forum (WEF) Annual Meeting in Davos. Published in partnership with the Community of European Management Schools (CEMS) and drawing on a decade of data covering over

SRS Real Estate Partners Expands Capital Markets Group; Adds High-Performing Team of 10 Professionals to its Newport Beach Office

Dallas, TX, United States, Jan. 23, 2025 (GLOBE NEWSWIRE) — SRS Real Estate Partners has significantly expanded its Capital Markets group with the addition of a proven, highly successful team of ten professionals who will be based out of the firm's Newport Beach office. Calvin Short, Aron Cline, and Gary Chou will serve as Executive

Workplace Options Unveils Comprehensive & Compassionate Return-to-Work Program for Cancer Survivors

RALEIGH, N.C., Jan. 23, 2025 (GLOBE NEWSWIRE) — Returning to work after a cancer diagnosis is a journey fraught with challenges–physical fatigue, emotional hurdles, and workplace reintegration complexities. To bridge this critical gap, Workplace Options (WPO), a global leader in holistic health and employee engagement solutions, introduces the Return to Work: Cancer Care Compass Program.

Digital Turbine to Host Fiscal 2025 Third Quarter Financial Results Conference Call on February 5, 2025, at 4:30pm ET

Digital Turbine, Inc. (Nasdaq: APPS), a global mobile platform company,announced it will host a conference call and webcast to discuss its fiscal 2025 third quarter financial results and operating progress on Wednesday, February 5th, at 4:30pm ET/1:30pm PT. The call, hosted by Digital Turbine's Chief Executive Officer Bill Stone and Chief Financial Officer Barrett Garrison,

NMI Holdings, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025

(NasdaqGM:NMIH), EMERYVILLE, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) — NMI Holdings, Inc. (NASDAQ: NMIH), the parent company of National Mortgage Insurance Corporation (National MI), today announced that it will report results for its fourth quarter and full year ended December 31, 2024 after the market close on Thursday, February 6, 2025. The company will hold

Aethir and Plume Network Launch RWAI Initiative to Advance Tokenized AI and GPU Assets

Aethir, a global leader in decentralized cloud computing for AI and gaming, and Plume Network, the first full-stack Layer 1 RWA Chain, have announced their collaboration to launch the RWAI Initiative. Together, they are spearheading efforts to integrate tokenized GPU assets with real world asset (RWA) strategies, making AI and GPU-driven finance more accessible to

Class Action Filed Against Revance Therapeutics, Inc. (RVNC) Seeking Recovery for Investors – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Revance Therapeutics, Inc. (NASDAQ:RVNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/revance-therapeutics-inc-lawsuit-submission-form?prid=124690&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations – Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights – REGN

NEW YORK, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=124688&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Scroll to Top